PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
18976971-9	2009	The use of an ELISA and zymography demonstrated that MMP-2 and MMP-9 enzyme activity were decreased in HT-29 cells by treatment with various concentration of 5-aminosalicylic acid.	Mesalamine	158-179	matrix metallopeptidase 9	Homo sapiens	63-68	
32017001-17	2020	CONCLUSIONS: Mesalazine combined with bifid triple viable is able to enhance the curative effect for UC, improve the composition of intestinal flora, weaken the immune response, and reduce levels of Cal and MMP-9 in the intestinal tract.	Mesalamine	13-23	matrix metallopeptidase 9	Homo sapiens	207-212	
26896068-11	2016	Metformin also enhanced the inhibitory effect of 5-ASA on MMP-2 and MMP-9 enzyme activity, indicating a decrease in metastasis.	Mesalamine	49-54	matrix metallopeptidase 9	Homo sapiens	68-73